Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000905718-21-000606
Filing Date
2021-04-20
Accepted
2021-04-20 16:07:37
Documents
2
Group Members
ABINGWORTH BIOVENTURES 8 LP

Document Format Files

Seq Description Document Type Size
1 SC 13D reneo_13dapr132021.htm SC 13D 63411
2 JOINT FILING AGREEMENT reneo_13dapr132021ex1.htm EX-1 7641
  Complete submission text file 0000905718-21-000606.txt   72519
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

EIN.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D

Mailing Address P.O. BOX 675614 RANCHO SANTA FE CA 92067
Business Address P.O. BOX 675614 RANCHO SANTA FE CA 92067 619-733-3852
Reneo Pharmaceuticals, Inc. (Subject) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92480 | Film No.: 21837926
SIC: 2834 Pharmaceutical Preparations